You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

Citation Tools

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Strand V, Mysler E, Moots RJ, et al
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
RMD Open 2019;5:e001040. doi: 10.1136/rmdopen-2019-001040